Alvotech (ALVO)
USD 8.31
(-0.18%)
USD 8.31
(-0.18%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -551.73 Million USD | -7.43% |
| 2022 | -513.58 Million USD | -405.97% |
| 2021 | -101.5 Million USD | 40.31% |
| 2020 | -170.04 Million USD | 18.98% |
| 2019 | -209.87 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -218.72 Million USD | 20.91% |
| 2024 Q2 | 65.22 Million USD | 129.82% |
| 2023 Q2 | 189.32 Million USD | 168.55% |
| 2023 Q1 | -276.18 Million USD | 13.83% |
| 2023 FY | -551.73 Million USD | -7.43% |
| 2023 Q3 | -188.32 Million USD | -199.47% |
| 2023 Q4 | -276.55 Million USD | -46.85% |
| 2022 Q1 | -76.97 Million USD | -130.34% |
| 2022 FY | -513.58 Million USD | -405.97% |
| 2022 Q4 | -320.5 Million USD | -3625.96% |
| 2022 Q3 | -8.6 Million USD | 92.0% |
| 2022 Q2 | -107.49 Million USD | -39.64% |
| 2021 FY | -101.5 Million USD | 40.31% |
| 2021 Q2 | -225.68 Thousand USD | -103.19% |
| 2021 Q3 | -81.31 Million USD | -35929.83% |
| 2021 Q4 | 253.75 Million USD | 412.07% |
| 2021 Q1 | 7.06 Million USD | 176.54% |
| 2020 FY | -170.04 Million USD | 18.98% |
| 2020 Q4 | -9.23 Million USD | 78.27% |
| 2020 Q3 | -42.51 Million USD | 0.0% |
| 2020 Q2 | -42.51 Million USD | 0.0% |
| 2020 Q1 | -42.51 Million USD | 18.98% |
| 2019 Q1 | -52.46 Million USD | 0.0% |
| 2019 Q2 | -52.46 Million USD | 0.0% |
| 2019 Q3 | -52.46 Million USD | 0.0% |
| 2019 Q4 | -52.46 Million USD | 0.0% |
| 2019 FY | -209.87 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 1245.74% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -17706.206% |
| Embecta Corp. | 70.4 Million USD | 883.709% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 1415.054% |
| PainReform Ltd. | -9.34 Million USD | -5804.655% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -12144.244% |
| SCYNEXIS, Inc. | 67.04 Million USD | 922.975% |
| Journey Medical Corporation | -3.85 Million USD | -14219.517% |
| Safety Shot Inc | -15.08 Million USD | -3557.956% |
| Alpha Teknova, Inc. | -36.78 Million USD | -1400.084% |
| Bright Green Corporation | -13.12 Million USD | -4102.817% |
| Procaps Group, S.A. | 42.54 Million USD | 1396.97% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 3038.021% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -6910.559% |
| Cosmos Health Inc. | -18.54 Million USD | -2875.469% |
| Dynavax Technologies Corporation | -6.38 Million USD | -8535.639% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | -163.673% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | -295.013% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -12144.244% |
| Theratechnologies Inc. | -23.95 Million USD | -2203.005% |
| Harrow Health, Inc. | -24.41 Million USD | -2160.174% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -11311.189% |
| Biofrontera Inc. | -20.13 Million USD | -2640.703% |
| DURECT Corporation | -27.62 Million USD | -1897.289% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 42024.848% |
| Cronos Group Inc. | -73.96 Million USD | -645.955% |
| OptiNose, Inc. | -35.48 Million USD | -1454.916% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 44.95% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | -1207.45% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 2406.954% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 11257.351% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 349223.917% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -8686.477% |
| Radius Health, Inc. | -25.79 Million USD | -2039.238% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -8852.224% |
| ProPhase Labs, Inc. | -16.78 Million USD | -3187.636% |
| Phibro Animal Health Corporation | 2.41 Million USD | 22936.548% |
| Procaps Group S.A. | 42.54 Million USD | 1396.97% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -5268.077% |
| Viatris Inc. | 54.7 Million USD | 1108.649% |
| Rockwell Medical, Inc. | -8.43 Million USD | -6437.872% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -3382.271% |
| SIGA Technologies, Inc. | 68.06 Million USD | 910.549% |
| Tilray Brands, Inc. | -244.98 Million USD | -125.214% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 4692.783% |
| Shineco, Inc. | -22.44 Million USD | -2357.707% |
| PetIQ, Inc. | 2.13 Million USD | 25990.709% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -12725.474% |
| Incannex Healthcare Limited | -18.45 Million USD | -2888.954% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 320.958% |
| Alimera Sciences, Inc. | -20.13 Million USD | -2640.567% |
| Silver Spike Investment Corp. | 7.34 Million USD | 7616.661% |
| Assertio Holdings, Inc. | -331.94 Million USD | -66.213% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -8268.788% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -6658.769% |
| Clever Leaves Holdings Inc. | -17.89 Million USD | -2982.468% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -2650.774% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | -244.238% |
| Hempacco Co., Inc. | -13.12 Million USD | -4103.319% |
| Talphera, Inc. | -18.39 Million USD | -2899.027% |
| Alvotech | -551.73 Million USD | -0.0% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 1647.98% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 268.9% |
| Currenc Group, Inc. | -15.3 Million USD | -3504.542% |
| Kamada Ltd. | 8.28 Million USD | 6760.2% |
| Indivior PLC | 2 Million USD | 27686.55% |
| Evoke Pharma, Inc. | -7.79 Million USD | -6980.469% |
| Flora Growth Corp. | -57.03 Million USD | -867.338% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -2650.774% |
| Evolus, Inc. | -61.68 Million USD | -794.433% |
| HUTCHMED (China) Limited | 100.78 Million USD | 647.461% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 501.128% |
| Akanda Corp. | -32.27 Million USD | -1609.465% |